The global infection surveillance solutions market size is expected to grow from USD 445.8 million in 2020 to USD 1,078.2 million by 2026 at a CAGR of 15.9%.

Based on the product, the infection surveillance solutions market is divided into infection surveillance software solutions and infection surveillance services. In 2020, the infection surveillance software segment hold the largest share of the infection surveillance solutions market. A large part of this segment is due to the increased need for HAI prevention and a growing number of surgical procedures.

By software, the infection surveillance software market is divided into on-premise and web-based software. In 2020, the on-premise software segment had the largest share of the infection surveillance software market. A large share of this segment is mainly due to the need to maintain access to IT healthcare solutions and to reduce the risk of data breaches and external attacks.

By service, the infection surveillance solutions market is divided into product support and maintenance services, training and consulting services, and implementation services. In 2020, the product support and maintenance services segment hold the largest share of the infection surveillance solutions market. Product support and maintenance services address software complexity-related issues. These services ensure that customers (healthcare providers) gain access to the vendor company's technical knowledge base, gain support from their product support team, and acquire application management skills. These factors drive the growth of the product support and repair services segment.

By end-user, the infection surveillance solutions market is divided into hospitals, long-term care facilities, and other end users. In 2020, the hospitals segment had the largest share in the infection surveillance solutions market. The major share of this segment can be attributed to the greater patient volume, increased HAI incidence, and increasing SSI conditions. The COVID-19 epidemic has also increased the adoption of hospital-based infection control solutions.

In 2020, North America had the largest share in the infection surveillance solutions market, followed by Europe, Asia Pacific, Latin America, and the Middle East and Africa. A large share of this region is due to factors such as increased resilience among healthcare providers, widespread adoption of IT healthcare solutions to reduce rising health care costs, increased incidence of HAIs, and an increasing number of COVID-19 patients in the US. . The presence of a large number of players in the region is also an important factor in the significant participation in the North American infection surveillance solutions market.

The major players operating in the infection surveillance solutions market include Becton, Dickinson and Company (US), Premier International, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), RLDatix (UK), GOJO Industries, Inc. (US), Sunquest (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), IBM Corporation (US), Vecna Technologies, Inc. (US), PeraHealth Inc. (US), VigiLanz Corporation (US), Ecolab Inc. (US), Harris Healthcare (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), Vitalacy Inc. (US), bioMerieux SA (France), STANLEY Healthcare (US), and Vizzia Technologies (US).

The growth of this market is largely due to the increase in cases of hospital-acquired infections (HAIs) and new Medicare policies, including non-payment of hospital-acquired conditions. The increase in the cost of health care, the increase in the number of surgeons, the increase in the number of elderly people, and the increase in the incidence of chronic diseases are some of the factors contributing to the growth of this market. Currently, due to the increase in COVID-19 cases, there is an increased focus on personal hygiene, which goes hand in hand with the need to track and monitor the spread of COVID-19 infections. This is expected to further market growth during the forecast period. In addition, the increase in healthcare costs, strong government support and programs, and a growing focus on quality patient care and safety are expected to support the growing infection surveillance solutions market worldwide.

On the other hand, the high cost of deploying IT health solutions to small healthcare organizations in developing countries and skepticism among medical professionals to find IT healthcare solutions for advanced health care are expected to hamper the growth of this market during forecasts.

COVID-19 is an infectious disease caused by a newly discovered novel coronavirus. Little known before the outbreak in Wuhan (China) in December 2019, COVID-19 moved from a regional crisis to a global epidemic within weeks. The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020. According to Worldometers, there have been 23.6 million confirmed COVID-19 cases worldwide since August 24, 2020. As a result, there was a severe shortage of beds, health care providers, and basic medical services in health care facilities. This forces health care organizations to develop HCIT solutions, such as infection control solutions, EHRs, telephone health forums, and patient registers, to track and monitor COVID-19 infections in patients and to collect better patient outcomes data.

COVID-19 has forced various government agencies and organizations to adopt digital technologies and IT healthcare solutions.

Hospital-acquired infections (HAIs) are nosocomial infections that occur during a patient's stay in hospitals and related facilities and are not detected at the time of admission. They are a major cause of sickness and death worldwide. These diseases include diseases that affect the central nervous system, surgical diseases, catheter-borne urinary tract infections, hospital-acquired pneumonia, ventilator-associated pneumonia, and Clostridiumsteile infections. The most common HAI-related viruses include C. difficile, MRSA, Klebsiella, E. coli, Enterococcus, and Pseudomonas species. The use of infected medical equipment during diagnostic and therapeutic procedures is a major cause of HAI. HAI cases are highly dependent on patients' immune status, infection control measures, and the spread of various viruses in health facilities. Other factors include prolonged hospital stay, immunosuppression, aging, and intensive care unit. About 20% of such infections occur in the ICU. Transmission can occur through direct contact with health care workers or the contaminated site. Pathogens tend to grow in warm and humid areas such as the inguinal and perineal areas, axilla, and trunk. A few governments and non-governmental organizations such as WHO, Joint Commission on the Accreditation of Healthcare Organizations (JCAHO), Centers for Disease Control and Prevention (CDC), Centers for Medicare & Medicaid Services (CMS), National Accreditation Board for Hospitals & Healthcare Providers (NABH), and the Association for Professionals in Infection Control and Epidemiology (APIC) are focused on curbing the increase in HAI cases.

The costs of working with and implementing software solutions are very high. Small healthcare organizations are struggling to make use of the Internet to implement IT healthcare IT solutions. This is due to the difficulty of using multiple networks with health settings, the lack of wireless connection options, and the need to install billions of security layers to avoid data breaches. The infection surveillance software has a high value. And many systems need to be customized to meet the needs of health facilities. In addition, support and maintenance services, which include software modification and development according to changing user needs, represent recurring costs, accounting for the bulk of all ownership costs. Also, the development of an after-sales interface for device integration requires additional verification and verification to ensure solution accuracy and completeness. This also increases the number of patent costs for health care providers. Smaller hospitals and health organizations cannot afford these additional costs.

Currently, the healthcare industry is increasingly consolidating into the US, and major regional and national health care programs are growing in size. In the US, the implementation of the PPCA in 2010 has authorized healthcare organizations across the country to use improved IT healthcare tools, which have also increased the financial burden on healthcare organizations. The implementation of such health care reforms affects the profit margins of hospitals, doctors, and insurance companies. To control the cost of health care delivery, health care organizations in the US are expanding their patient base and improving the use of available resources. In this regard, integration is one of the most preferred methods used by health care providers to expand their patients and make full use of resources. According to the American Hospital Association Survey, 2019, of the approximately 5,200 hospitals in the US, about 65% are part of a larger health system.

Successful implementation of infection surveillance solutions requires strong IT infrastructure and IT support within the organization and end of the solution provider. In a health care organization, there is an ongoing need for technical support to maintain servers and networks to effectively streamline clinical operations and greater connectivity for monitoring systems. When a server or network maintenance is inadequate, it leads to the production of screen load, which reduces the flow of clinical activity. As health care organizations become more complex with their IT systems, labor leaders face a new set of recruitment challenges. Lack of appropriate resources is a major obstacle to implementing infection control solutions in hospitals. Currently, the demand for HCIT professionals far exceeds their supply in both emerging and developed markets.